DANIEL WELCH: Open Payments
NPI 1497396394 · COOS BAY, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 10 payments from 10 companies in 2025. Trend: 2023 $2,547 · 2024 $404 · 2025 $262
Food & beverage: $262
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
| BeOne Medicines USA, Inc. | 1 | $25 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $21 |
| Genentech USA, Inc. | 1 | $19 |
| Aveo Pharmaceuticals, Inc. | 1 | $19 |
Products named: LYNPARZA, OJJAARA, TECVAYLI, EPKINLY, KEYTRUDA, BRUKINSA, ZYNLONTA, Polivy.
Industry payments across OR — which companies pay providers there.
